A retrospective study to assess efficacy and safety of Paclitaxel/ramucirumab versus FOLFIRI as second line chemotherapy in patients with metastatic gastric cancer
Latest Information Update: 16 Oct 2020
At a glance
- Drugs Paclitaxel (Primary) ; Ramucirumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms PARAFIRIGAST
- 16 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress